Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: Analysis of survival and update of efficacy from the international letrozole breast cancer group

被引：23
作者：
Buzdar, AU [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 15期
关键词：
D O I：
10.1200/JCO.2004.99.058
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3199 / 3200
页数：2
相关论文
共 6 条
[1]   Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women:: Results of the tamoxifen or arimidex randomized group efficacy and tolerability study [J].
Bonneterre, J ;
Thürlimann, B ;
Robertson, JFR ;
Krzakowski, M ;
Mauriac, L ;
Koralewski, P ;
Vergote, I ;
Webster, A ;
Steinberg, M ;
von Euler, M .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (22) :3748-3757
[2]   Superior efficacy of letrozole versus tamoxifen as first-line therapy [J].
Buzdar, AU .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (03) :876-877
[3]  
MILLASANTOS A, 2000, AM J CLIN ONCO, V26, P317
[4]   Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women:: Analysis of survival and update of efficacy from the international letrozole breast cancer group [J].
Mouridsen, H ;
Gershanovick, M ;
Sun, Y ;
Pérez-Carrión, R ;
Boni, C ;
Monnier, A ;
Apffelstaedt, J ;
Smith, R ;
Sleeboom, HP ;
Jaenicke, F ;
Pluzanska, A ;
Dank, M ;
Becquart, D ;
Bapsy, PP ;
Salminen, E ;
Snyder, R ;
Chaudri-Ross, H ;
Lang, R ;
Wyld, P ;
Bhatnagar, A .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (11) :2101-2109
[5]   Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: Results of a North American multicenter randomized trial [J].
Nabholtz, JM ;
Buzdar, A ;
Pollak, M ;
Harwin, W ;
Burton, G ;
Mangalik, A ;
Steinberg, M ;
Webster, A ;
von Euler, M .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (22) :3758-3767
[6]   Anastrozole (Arimidex™) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women:: survival analysis and updated safety results [J].
Nabholtz, JM ;
Bonneterre, J ;
Buzdar, A ;
Robertson, JFR ;
Thürlimann, B .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (12) :1684-1689
1